Meeting
Abstract Number: 118
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Guidelines recommend pharmacologic venous thromboembolism (VTE) prophylaxis for high risk hospitalized medical patients that do not have an elevated bleeding risk. A systematic review of randomized trials estimates the overall bleeding risk with pharmacologic prophylaxis to be low, at 1/1000 (0.1%). However, it is unclear if the bleeding events were related to pharmacologic prophylaxis […]
Abstract Number: 214
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Current national guidelines recommend using mechanical methods for venous thromboembolism (VTE) prophylaxis in hospitalized medical patients at elevated risk for thrombosis who have a contraindication to pharmacologic prophylaxis. Additionally, it is recommended to avoid the use of mechanical prophylaxis for patients who are at low risk for VTE. The Michigan Hospital Medicine Safety Consortium, […]
Abstract Number: 307
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Venous thromboembolism (VTE) is a common preventable condition in hospitalized medical patients. Chemoprophylaxis with heparin or fondaparinux has been recommended for all hospitalized patients who are not at low risk, and appropriate thromboprophylaxis is a hospital quality measure. However, the specific threshold of VTE risk that warrants prophylaxis has not been defined. We used […]